Understanding 21 CFR Part 11: The FDA’s Framework for Digital Records and Signatures
In today’s digital era, electronic systems have become essential for driving efficiency and ensuring compliance in regulated industries. From pharmaceuticals to biotechnology, companies rely on digital tools to manage data, streamline processes, and maintain quality standards. However, the shift from paper-based processes to digital systems brought an increased demand for regulatory oversight to ensure that […]
Understanding 21 CFR Part 11: The FDA’s Framework for Digital Records and Signatures Read More »








